nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ABCC1—Vemurafenib—skin cancer	0.0962	0.126	CbGbCtD
Irinotecan—ABCG2—Vismodegib—skin cancer	0.0815	0.107	CbGbCtD
Irinotecan—ABCG2—Vemurafenib—skin cancer	0.0644	0.0844	CbGbCtD
Irinotecan—ABCC1—Dactinomycin—skin cancer	0.064	0.0838	CbGbCtD
Irinotecan—ALB—Vismodegib—skin cancer	0.0562	0.0736	CbGbCtD
Irinotecan—ALB—Vemurafenib—skin cancer	0.0444	0.0582	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—skin cancer	0.0428	0.0561	CbGbCtD
Irinotecan—ABCC1—Docetaxel—skin cancer	0.033	0.0433	CbGbCtD
Irinotecan—ABCB1—Vismodegib—skin cancer	0.0294	0.0385	CbGbCtD
Irinotecan—ABCG2—Fluorouracil—skin cancer	0.0289	0.0379	CbGbCtD
Irinotecan—CYP3A4—Temozolomide—skin cancer	0.0254	0.0333	CbGbCtD
Irinotecan—CYP3A4—Imiquimod—skin cancer	0.0254	0.0333	CbGbCtD
Irinotecan—ABCC2—Docetaxel—skin cancer	0.0244	0.032	CbGbCtD
Irinotecan—ABCG2—Docetaxel—skin cancer	0.0221	0.029	CbGbCtD
Irinotecan—ALB—Fluorouracil—skin cancer	0.0199	0.0262	CbGbCtD
Irinotecan—CYP3A4—Vismodegib—skin cancer	0.0176	0.0231	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—skin cancer	0.0163	0.0214	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0163	0.0214	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—skin cancer	0.0154	0.0202	CbGbCtD
Irinotecan—CYP3A4—Vemurafenib—skin cancer	0.0139	0.0182	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—skin cancer	0.0122	0.016	CbGbCtD
Irinotecan—ABCB1—Docetaxel—skin cancer	0.00797	0.0104	CbGbCtD
Irinotecan—CYP3A4—Docetaxel—skin cancer	0.00477	0.00626	CbGbCtD
Irinotecan—TOP1—hair follicle—skin cancer	0.00249	0.0785	CbGeAlD
Irinotecan—TOP1—nipple—skin cancer	0.00169	0.0532	CbGeAlD
Irinotecan—TOP1MT—female reproductive system—skin cancer	0.0016	0.0505	CbGeAlD
Irinotecan—CES2—nipple—skin cancer	0.00153	0.0483	CbGeAlD
Irinotecan—TOP1MT—head—skin cancer	0.00134	0.0422	CbGeAlD
Irinotecan—CES1—neck—skin cancer	0.00125	0.0393	CbGeAlD
Irinotecan—ABCC1—hair follicle—skin cancer	0.00107	0.0336	CbGeAlD
Irinotecan—TOP1—mammalian vulva—skin cancer	0.000987	0.0311	CbGeAlD
Irinotecan—CES2—skin of body—skin cancer	0.000982	0.0309	CbGeAlD
Irinotecan—TOP1MT—lymph node—skin cancer	0.000937	0.0295	CbGeAlD
Irinotecan—CES2—mammalian vulva—skin cancer	0.000895	0.0282	CbGeAlD
Irinotecan—CES1—connective tissue—skin cancer	0.000895	0.0282	CbGeAlD
Irinotecan—SLC22A3—nipple—skin cancer	0.000876	0.0276	CbGeAlD
Irinotecan—CES2—female reproductive system—skin cancer	0.000767	0.0241	CbGeAlD
Irinotecan—ABCC1—nipple—skin cancer	0.000724	0.0228	CbGeAlD
Irinotecan—CES2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000684	0.128	CbGpPWpGaD
Irinotecan—CES1—lymphoid tissue—skin cancer	0.000655	0.0206	CbGeAlD
Irinotecan—CES2—head—skin cancer	0.00064	0.0202	CbGeAlD
Irinotecan—CES1—female reproductive system—skin cancer	0.000631	0.0199	CbGeAlD
Irinotecan—SLC22A3—connective tissue—skin cancer	0.000621	0.0196	CbGeAlD
Irinotecan—BCHE—nipple—skin cancer	0.00062	0.0195	CbGeAlD
Irinotecan—SLCO1B1—female reproductive system—skin cancer	0.000542	0.0171	CbGeAlD
Irinotecan—CES1—head—skin cancer	0.000527	0.0166	CbGeAlD
Irinotecan—SLC22A3—mammalian vulva—skin cancer	0.000512	0.0161	CbGeAlD
Irinotecan—TOP1—lymph node—skin cancer	0.000494	0.0156	CbGeAlD
Irinotecan—CES2—lymph node—skin cancer	0.000448	0.0141	CbGeAlD
Irinotecan—SLC22A3—female reproductive system—skin cancer	0.000438	0.0138	CbGeAlD
Irinotecan—ABCC1—mammalian vulva—skin cancer	0.000423	0.0133	CbGeAlD
Irinotecan—ABCC2—female reproductive system—skin cancer	0.000411	0.0129	CbGeAlD
Irinotecan—ABCB1—blood vessel—skin cancer	0.000409	0.0129	CbGeAlD
Irinotecan—CES1—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000403	0.0755	CbGpPWpGaD
Irinotecan—BCHE—skin of body—skin cancer	0.000397	0.0125	CbGeAlD
Irinotecan—ACHE—lymph node—skin cancer	0.000369	0.0116	CbGeAlD
Irinotecan—CES1—lymph node—skin cancer	0.000369	0.0116	CbGeAlD
Irinotecan—SLC22A3—head—skin cancer	0.000366	0.0115	CbGeAlD
Irinotecan—BCHE—mammalian vulva—skin cancer	0.000362	0.0114	CbGeAlD
Irinotecan—CYP2B6—skin of body—skin cancer	0.000354	0.0112	CbGeAlD
Irinotecan—ABCG2—mammalian vulva—skin cancer	0.00035	0.011	CbGeAlD
Irinotecan—Angina pectoris—Fluorouracil—skin cancer	0.000347	0.00173	CcSEcCtD
Irinotecan—Pneumonia—Temozolomide—skin cancer	0.000347	0.00173	CcSEcCtD
Irinotecan—Thrombophlebitis—Docetaxel—skin cancer	0.000344	0.00172	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000342	0.00171	CcSEcCtD
Irinotecan—Flushing—Bleomycin—skin cancer	0.00034	0.0017	CcSEcCtD
Irinotecan—Body temperature increased—Vemurafenib—skin cancer	0.00034	0.0017	CcSEcCtD
Irinotecan—Stomatitis—Temozolomide—skin cancer	0.000336	0.00168	CcSEcCtD
Irinotecan—Insomnia—Imiquimod—skin cancer	0.000332	0.00166	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000331	0.00165	CcSEcCtD
Irinotecan—Paraesthesia—Imiquimod—skin cancer	0.000329	0.00165	CcSEcCtD
Irinotecan—Chills—Bleomycin—skin cancer	0.000329	0.00165	CcSEcCtD
Irinotecan—Dyspnoea—Imiquimod—skin cancer	0.000327	0.00163	CcSEcCtD
Irinotecan—Somnolence—Imiquimod—skin cancer	0.000326	0.00163	CcSEcCtD
Irinotecan—Alopecia—Bleomycin—skin cancer	0.000324	0.00162	CcSEcCtD
Irinotecan—Dyspepsia—Imiquimod—skin cancer	0.000323	0.00161	CcSEcCtD
Irinotecan—Pneumonia—Fluorouracil—skin cancer	0.000319	0.0016	CcSEcCtD
Irinotecan—Decreased appetite—Imiquimod—skin cancer	0.000319	0.00159	CcSEcCtD
Irinotecan—Flushing—Dactinomycin—skin cancer	0.000318	0.00159	CcSEcCtD
Irinotecan—Hypersensitivity—Vemurafenib—skin cancer	0.000317	0.00158	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Imiquimod—skin cancer	0.000317	0.00158	CcSEcCtD
Irinotecan—Fatigue—Imiquimod—skin cancer	0.000316	0.00158	CcSEcCtD
Irinotecan—Visual disturbance—Docetaxel—skin cancer	0.000314	0.00157	CcSEcCtD
Irinotecan—Pain—Imiquimod—skin cancer	0.000314	0.00157	CcSEcCtD
Irinotecan—Acute coronary syndrome—Fluorouracil—skin cancer	0.000313	0.00156	CcSEcCtD
Irinotecan—Renal impairment—Docetaxel—skin cancer	0.000313	0.00156	CcSEcCtD
Irinotecan—Myocardial infarction—Fluorouracil—skin cancer	0.000311	0.00156	CcSEcCtD
Irinotecan—Haemoglobin—Temozolomide—skin cancer	0.000311	0.00155	CcSEcCtD
Irinotecan—BCHE—female reproductive system—skin cancer	0.00031	0.00977	CbGeAlD
Irinotecan—Stomatitis—Fluorouracil—skin cancer	0.00031	0.00155	CcSEcCtD
Irinotecan—Haemorrhage—Temozolomide—skin cancer	0.000309	0.00155	CcSEcCtD
Irinotecan—Asthenia—Vemurafenib—skin cancer	0.000309	0.00154	CcSEcCtD
Irinotecan—Chills—Dactinomycin—skin cancer	0.000307	0.00153	CcSEcCtD
Irinotecan—Connective tissue disorder—Temozolomide—skin cancer	0.000304	0.00152	CcSEcCtD
Irinotecan—Alopecia—Dactinomycin—skin cancer	0.000302	0.00151	CcSEcCtD
Irinotecan—Feeling abnormal—Imiquimod—skin cancer	0.000302	0.00151	CcSEcCtD
Irinotecan—Gastrointestinal pain—Imiquimod—skin cancer	0.0003	0.0015	CcSEcCtD
Irinotecan—Hyponatraemia—Docetaxel—skin cancer	0.000299	0.00149	CcSEcCtD
Irinotecan—Visual impairment—Temozolomide—skin cancer	0.000298	0.00149	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000297	0.00149	CcSEcCtD
Irinotecan—Ill-defined disorder—Bleomycin—skin cancer	0.000296	0.00148	CcSEcCtD
Irinotecan—Anaemia—Bleomycin—skin cancer	0.000295	0.00148	CcSEcCtD
Irinotecan—Diarrhoea—Vemurafenib—skin cancer	0.000294	0.00147	CcSEcCtD
Irinotecan—Abdominal pain—Imiquimod—skin cancer	0.00029	0.00145	CcSEcCtD
Irinotecan—Body temperature increased—Imiquimod—skin cancer	0.00029	0.00145	CcSEcCtD
Irinotecan—Malaise—Bleomycin—skin cancer	0.000288	0.00144	CcSEcCtD
Irinotecan—Flushing—Temozolomide—skin cancer	0.000287	0.00144	CcSEcCtD
Irinotecan—Cardiac disorder—Temozolomide—skin cancer	0.000287	0.00144	CcSEcCtD
Irinotecan—CYP2B6—lymphoid tissue—skin cancer	0.000287	0.00903	CbGeAlD
Irinotecan—Haemoglobin—Fluorouracil—skin cancer	0.000287	0.00143	CcSEcCtD
Irinotecan—Leukopenia—Bleomycin—skin cancer	0.000286	0.00143	CcSEcCtD
Irinotecan—Rhinitis—Fluorouracil—skin cancer	0.000286	0.00143	CcSEcCtD
Irinotecan—Haemorrhage—Fluorouracil—skin cancer	0.000285	0.00143	CcSEcCtD
Irinotecan—Dizziness—Vemurafenib—skin cancer	0.000284	0.00142	CcSEcCtD
Irinotecan—Angiopathy—Temozolomide—skin cancer	0.000281	0.0014	CcSEcCtD
Irinotecan—Immune system disorder—Temozolomide—skin cancer	0.000279	0.0014	CcSEcCtD
Irinotecan—Mediastinal disorder—Temozolomide—skin cancer	0.000279	0.00139	CcSEcCtD
Irinotecan—Cough—Bleomycin—skin cancer	0.000279	0.00139	CcSEcCtD
Irinotecan—Chills—Temozolomide—skin cancer	0.000278	0.00139	CcSEcCtD
Irinotecan—CYP2B6—female reproductive system—skin cancer	0.000277	0.00871	CbGeAlD
Irinotecan—Dehydration—Docetaxel—skin cancer	0.000277	0.00138	CcSEcCtD
Irinotecan—Ill-defined disorder—Dactinomycin—skin cancer	0.000276	0.00138	CcSEcCtD
Irinotecan—SLC22A3—Synaptic Vesicle Pathway—SYP—skin cancer	0.000276	0.0517	CbGpPWpGaD
Irinotecan—Anaemia—Dactinomycin—skin cancer	0.000275	0.00138	CcSEcCtD
Irinotecan—Vomiting—Vemurafenib—skin cancer	0.000273	0.00137	CcSEcCtD
Irinotecan—Alopecia—Temozolomide—skin cancer	0.000273	0.00137	CcSEcCtD
Irinotecan—Orthostatic hypotension—Docetaxel—skin cancer	0.000272	0.00136	CcSEcCtD
Irinotecan—Rash—Vemurafenib—skin cancer	0.000271	0.00136	CcSEcCtD
Irinotecan—Dermatitis—Vemurafenib—skin cancer	0.000271	0.00135	CcSEcCtD
Irinotecan—Hypersensitivity—Imiquimod—skin cancer	0.00027	0.00135	CcSEcCtD
Irinotecan—Headache—Vemurafenib—skin cancer	0.000269	0.00135	CcSEcCtD
Irinotecan—Discomfort—Bleomycin—skin cancer	0.000269	0.00134	CcSEcCtD
Irinotecan—Malaise—Dactinomycin—skin cancer	0.000269	0.00134	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000268	0.00134	CcSEcCtD
Irinotecan—Cramp muscle—Docetaxel—skin cancer	0.000268	0.00134	CcSEcCtD
Irinotecan—Leukopenia—Dactinomycin—skin cancer	0.000267	0.00133	CcSEcCtD
Irinotecan—CES2—E2F transcription factor network—XRCC1—skin cancer	0.000263	0.0493	CbGpPWpGaD
Irinotecan—Asthenia—Imiquimod—skin cancer	0.000263	0.00132	CcSEcCtD
Irinotecan—Confusional state—Bleomycin—skin cancer	0.000263	0.00131	CcSEcCtD
Irinotecan—Oedema—Bleomycin—skin cancer	0.000261	0.0013	CcSEcCtD
Irinotecan—Anaphylactic shock—Bleomycin—skin cancer	0.000261	0.0013	CcSEcCtD
Irinotecan—Back pain—Temozolomide—skin cancer	0.000261	0.0013	CcSEcCtD
Irinotecan—BCHE—head—skin cancer	0.000259	0.00816	CbGeAlD
Irinotecan—Infection—Bleomycin—skin cancer	0.000259	0.00129	CcSEcCtD
Irinotecan—ALB—lymph node—skin cancer	0.000257	0.00808	CbGeAlD
Irinotecan—SLC22A3—lymph node—skin cancer	0.000256	0.00807	CbGeAlD
Irinotecan—Nausea—Vemurafenib—skin cancer	0.000256	0.00128	CcSEcCtD
Irinotecan—Thrombocytopenia—Bleomycin—skin cancer	0.000255	0.00128	CcSEcCtD
Irinotecan—Arrhythmia—Fluorouracil—skin cancer	0.000255	0.00127	CcSEcCtD
Irinotecan—Alopecia—Fluorouracil—skin cancer	0.000252	0.00126	CcSEcCtD
Irinotecan—Diarrhoea—Imiquimod—skin cancer	0.000251	0.00125	CcSEcCtD
Irinotecan—Discomfort—Dactinomycin—skin cancer	0.000251	0.00125	CcSEcCtD
Irinotecan—Angina pectoris—Docetaxel—skin cancer	0.00025	0.00125	CcSEcCtD
Irinotecan—Ill-defined disorder—Temozolomide—skin cancer	0.00025	0.00125	CcSEcCtD
Irinotecan—Anaemia—Temozolomide—skin cancer	0.000249	0.00124	CcSEcCtD
Irinotecan—Anorexia—Bleomycin—skin cancer	0.000248	0.00124	CcSEcCtD
Irinotecan—Hypotension—Bleomycin—skin cancer	0.000244	0.00122	CcSEcCtD
Irinotecan—Oedema—Dactinomycin—skin cancer	0.000243	0.00121	CcSEcCtD
Irinotecan—Malaise—Temozolomide—skin cancer	0.000243	0.00121	CcSEcCtD
Irinotecan—Dizziness—Imiquimod—skin cancer	0.000243	0.00121	CcSEcCtD
Irinotecan—Vertigo—Temozolomide—skin cancer	0.000242	0.00121	CcSEcCtD
Irinotecan—Infection—Dactinomycin—skin cancer	0.000241	0.00121	CcSEcCtD
Irinotecan—Leukopenia—Temozolomide—skin cancer	0.000241	0.00121	CcSEcCtD
Irinotecan—CES2—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000241	0.0451	CbGpPWpGaD
Irinotecan—ABCC2—lymph node—skin cancer	0.000241	0.00757	CbGeAlD
Irinotecan—Neutropenia—Docetaxel—skin cancer	0.00024	0.0012	CcSEcCtD
Irinotecan—Thrombocytopenia—Dactinomycin—skin cancer	0.000238	0.00119	CcSEcCtD
Irinotecan—Cough—Temozolomide—skin cancer	0.000235	0.00117	CcSEcCtD
Irinotecan—Paraesthesia—Bleomycin—skin cancer	0.000234	0.00117	CcSEcCtD
Irinotecan—Vomiting—Imiquimod—skin cancer	0.000233	0.00117	CcSEcCtD
Irinotecan—Weight decreased—Docetaxel—skin cancer	0.000233	0.00116	CcSEcCtD
Irinotecan—Hypertension—Temozolomide—skin cancer	0.000233	0.00116	CcSEcCtD
Irinotecan—Dyspnoea—Bleomycin—skin cancer	0.000232	0.00116	CcSEcCtD
Irinotecan—Anorexia—Dactinomycin—skin cancer	0.000232	0.00116	CcSEcCtD
Irinotecan—Rash—Imiquimod—skin cancer	0.000231	0.00116	CcSEcCtD
Irinotecan—CYP2B6—head—skin cancer	0.000231	0.00728	CbGeAlD
Irinotecan—Dermatitis—Imiquimod—skin cancer	0.000231	0.00116	CcSEcCtD
Irinotecan—Pneumonia—Docetaxel—skin cancer	0.000231	0.00115	CcSEcCtD
Irinotecan—Headache—Imiquimod—skin cancer	0.00023	0.00115	CcSEcCtD
Irinotecan—Anaemia—Fluorouracil—skin cancer	0.000229	0.00115	CcSEcCtD
Irinotecan—Discomfort—Temozolomide—skin cancer	0.000227	0.00113	CcSEcCtD
Irinotecan—Decreased appetite—Bleomycin—skin cancer	0.000227	0.00113	CcSEcCtD
Irinotecan—Acute coronary syndrome—Docetaxel—skin cancer	0.000226	0.00113	CcSEcCtD
Irinotecan—Renal failure—Docetaxel—skin cancer	0.000225	0.00113	CcSEcCtD
Irinotecan—Myocardial infarction—Docetaxel—skin cancer	0.000225	0.00112	CcSEcCtD
Irinotecan—Stomatitis—Docetaxel—skin cancer	0.000223	0.00112	CcSEcCtD
Irinotecan—Jaundice—Docetaxel—skin cancer	0.000223	0.00112	CcSEcCtD
Irinotecan—Pain—Bleomycin—skin cancer	0.000223	0.00111	CcSEcCtD
Irinotecan—Leukopenia—Fluorouracil—skin cancer	0.000222	0.00111	CcSEcCtD
Irinotecan—Confusional state—Temozolomide—skin cancer	0.000222	0.00111	CcSEcCtD
Irinotecan—Anaphylactic shock—Temozolomide—skin cancer	0.00022	0.0011	CcSEcCtD
Irinotecan—Oedema—Temozolomide—skin cancer	0.00022	0.0011	CcSEcCtD
Irinotecan—Infection—Temozolomide—skin cancer	0.000218	0.00109	CcSEcCtD
Irinotecan—Nausea—Imiquimod—skin cancer	0.000218	0.00109	CcSEcCtD
Irinotecan—Nervous system disorder—Temozolomide—skin cancer	0.000216	0.00108	CcSEcCtD
Irinotecan—Thrombocytopenia—Temozolomide—skin cancer	0.000215	0.00108	CcSEcCtD
Irinotecan—Feeling abnormal—Bleomycin—skin cancer	0.000215	0.00107	CcSEcCtD
Irinotecan—Hyperhidrosis—Temozolomide—skin cancer	0.000213	0.00106	CcSEcCtD
Irinotecan—ABCC1—lymph node—skin cancer	0.000212	0.00667	CbGeAlD
Irinotecan—Decreased appetite—Dactinomycin—skin cancer	0.000211	0.00106	CcSEcCtD
Irinotecan—Fatigue—Dactinomycin—skin cancer	0.00021	0.00105	CcSEcCtD
Irinotecan—Anorexia—Temozolomide—skin cancer	0.00021	0.00105	CcSEcCtD
Irinotecan—CYP3A4—female reproductive system—skin cancer	0.000209	0.00658	CbGeAlD
Irinotecan—Discomfort—Fluorouracil—skin cancer	0.000209	0.00104	CcSEcCtD
Irinotecan—Pain—Dactinomycin—skin cancer	0.000208	0.00104	CcSEcCtD
Irinotecan—TOP1—Circadian rythm related genes—NKX2-1—skin cancer	0.000207	0.0388	CbGpPWpGaD
Irinotecan—Haemoglobin—Docetaxel—skin cancer	0.000207	0.00103	CcSEcCtD
Irinotecan—Rhinitis—Docetaxel—skin cancer	0.000206	0.00103	CcSEcCtD
Irinotecan—Body temperature increased—Bleomycin—skin cancer	0.000206	0.00103	CcSEcCtD
Irinotecan—Haemorrhage—Docetaxel—skin cancer	0.000206	0.00103	CcSEcCtD
Irinotecan—Confusional state—Fluorouracil—skin cancer	0.000204	0.00102	CcSEcCtD
Irinotecan—Anaphylactic shock—Fluorouracil—skin cancer	0.000203	0.00101	CcSEcCtD
Irinotecan—Oedema—Fluorouracil—skin cancer	0.000203	0.00101	CcSEcCtD
Irinotecan—Connective tissue disorder—Docetaxel—skin cancer	0.000202	0.00101	CcSEcCtD
Irinotecan—Infection—Fluorouracil—skin cancer	0.000201	0.00101	CcSEcCtD
Irinotecan—Feeling abnormal—Dactinomycin—skin cancer	0.0002	0.001	CcSEcCtD
Irinotecan—ABCB1—epithelium—skin cancer	0.000199	0.00627	CbGeAlD
Irinotecan—Insomnia—Temozolomide—skin cancer	0.000199	0.000994	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000199	0.000993	CcSEcCtD
Irinotecan—Nervous system disorder—Fluorouracil—skin cancer	0.000199	0.000993	CcSEcCtD
Irinotecan—Thrombocytopenia—Fluorouracil—skin cancer	0.000198	0.000991	CcSEcCtD
Irinotecan—Visual impairment—Docetaxel—skin cancer	0.000198	0.000991	CcSEcCtD
Irinotecan—Paraesthesia—Temozolomide—skin cancer	0.000197	0.000987	CcSEcCtD
Irinotecan—Dyspnoea—Temozolomide—skin cancer	0.000196	0.00098	CcSEcCtD
Irinotecan—Somnolence—Temozolomide—skin cancer	0.000195	0.000977	CcSEcCtD
Irinotecan—Dyspepsia—Temozolomide—skin cancer	0.000194	0.000967	CcSEcCtD
Irinotecan—Anorexia—Fluorouracil—skin cancer	0.000193	0.000965	CcSEcCtD
Irinotecan—Body temperature increased—Dactinomycin—skin cancer	0.000192	0.00096	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—skin cancer	0.000192	0.00096	CcSEcCtD
Irinotecan—Hypersensitivity—Bleomycin—skin cancer	0.000192	0.00096	CcSEcCtD
Irinotecan—Decreased appetite—Temozolomide—skin cancer	0.000191	0.000955	CcSEcCtD
Irinotecan—Flushing—Docetaxel—skin cancer	0.000191	0.000955	CcSEcCtD
Irinotecan—Cardiac disorder—Docetaxel—skin cancer	0.000191	0.000955	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Temozolomide—skin cancer	0.00019	0.000949	CcSEcCtD
Irinotecan—Fatigue—Temozolomide—skin cancer	0.00019	0.000947	CcSEcCtD
Irinotecan—Hypotension—Fluorouracil—skin cancer	0.000189	0.000946	CcSEcCtD
Irinotecan—Pain—Temozolomide—skin cancer	0.000188	0.00094	CcSEcCtD
Irinotecan—Constipation—Temozolomide—skin cancer	0.000188	0.00094	CcSEcCtD
Irinotecan—Asthenia—Bleomycin—skin cancer	0.000187	0.000935	CcSEcCtD
Irinotecan—Angiopathy—Docetaxel—skin cancer	0.000187	0.000933	CcSEcCtD
Irinotecan—Immune system disorder—Docetaxel—skin cancer	0.000186	0.000929	CcSEcCtD
Irinotecan—Mediastinal disorder—Docetaxel—skin cancer	0.000185	0.000927	CcSEcCtD
Irinotecan—Chills—Docetaxel—skin cancer	0.000185	0.000923	CcSEcCtD
Irinotecan—Arrhythmia—Docetaxel—skin cancer	0.000184	0.000919	CcSEcCtD
Irinotecan—Insomnia—Fluorouracil—skin cancer	0.000183	0.000916	CcSEcCtD
Irinotecan—Paraesthesia—Fluorouracil—skin cancer	0.000182	0.000909	CcSEcCtD
Irinotecan—Alopecia—Docetaxel—skin cancer	0.000182	0.000909	CcSEcCtD
Irinotecan—BCHE—lymph node—skin cancer	0.000182	0.00572	CbGeAlD
Irinotecan—Feeling abnormal—Temozolomide—skin cancer	0.000181	0.000905	CcSEcCtD
Irinotecan—Dyspnoea—Fluorouracil—skin cancer	0.000181	0.000903	CcSEcCtD
Irinotecan—Somnolence—Fluorouracil—skin cancer	0.00018	0.0009	CcSEcCtD
Irinotecan—Gastrointestinal pain—Temozolomide—skin cancer	0.00018	0.000899	CcSEcCtD
Irinotecan—Hypersensitivity—Dactinomycin—skin cancer	0.000179	0.000895	CcSEcCtD
Irinotecan—Dyspepsia—Fluorouracil—skin cancer	0.000178	0.000891	CcSEcCtD
Irinotecan—Decreased appetite—Fluorouracil—skin cancer	0.000176	0.00088	CcSEcCtD
Irinotecan—ABCG2—lymph node—skin cancer	0.000175	0.00552	CbGeAlD
Irinotecan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000175	0.000874	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—skin cancer	0.000174	0.000872	CcSEcCtD
Irinotecan—Abdominal pain—Temozolomide—skin cancer	0.000174	0.000869	CcSEcCtD
Irinotecan—Body temperature increased—Temozolomide—skin cancer	0.000174	0.000869	CcSEcCtD
Irinotecan—Back pain—Docetaxel—skin cancer	0.000173	0.000866	CcSEcCtD
Irinotecan—Pain—Fluorouracil—skin cancer	0.000173	0.000866	CcSEcCtD
Irinotecan—ABCB1—mammalian vulva—skin cancer	0.000173	0.00544	CbGeAlD
Irinotecan—Muscle spasms—Docetaxel—skin cancer	0.000172	0.000861	CcSEcCtD
Irinotecan—Feeling abnormal—Fluorouracil—skin cancer	0.000167	0.000834	CcSEcCtD
Irinotecan—Diarrhoea—Dactinomycin—skin cancer	0.000166	0.000831	CcSEcCtD
Irinotecan—Vomiting—Bleomycin—skin cancer	0.000166	0.000828	CcSEcCtD
Irinotecan—Anaemia—Docetaxel—skin cancer	0.000166	0.000828	CcSEcCtD
Irinotecan—Rash—Bleomycin—skin cancer	0.000164	0.000821	CcSEcCtD
Irinotecan—Dermatitis—Bleomycin—skin cancer	0.000164	0.000821	CcSEcCtD
Irinotecan—Hypersensitivity—Temozolomide—skin cancer	0.000162	0.00081	CcSEcCtD
Irinotecan—Syncope—Docetaxel—skin cancer	0.000161	0.000803	CcSEcCtD
Irinotecan—Leukopenia—Docetaxel—skin cancer	0.00016	0.000801	CcSEcCtD
Irinotecan—Body temperature increased—Fluorouracil—skin cancer	0.00016	0.0008	CcSEcCtD
Irinotecan—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00016	0.0299	CbGpPWpGaD
Irinotecan—Asthenia—Temozolomide—skin cancer	0.000158	0.000788	CcSEcCtD
Irinotecan—Loss of consciousness—Docetaxel—skin cancer	0.000157	0.000787	CcSEcCtD
Irinotecan—Cough—Docetaxel—skin cancer	0.000156	0.000781	CcSEcCtD
Irinotecan—CES1—E2F transcription factor network—XRCC1—skin cancer	0.000155	0.0291	CbGpPWpGaD
Irinotecan—Nausea—Bleomycin—skin cancer	0.000155	0.000774	CcSEcCtD
Irinotecan—Hypertension—Docetaxel—skin cancer	0.000155	0.000773	CcSEcCtD
Irinotecan—Vomiting—Dactinomycin—skin cancer	0.000155	0.000772	CcSEcCtD
Irinotecan—ABCB1—lymphoid tissue—skin cancer	0.000153	0.00483	CbGeAlD
Irinotecan—Rash—Dactinomycin—skin cancer	0.000153	0.000766	CcSEcCtD
Irinotecan—Diarrhoea—Temozolomide—skin cancer	0.00015	0.000752	CcSEcCtD
Irinotecan—Hypersensitivity—Fluorouracil—skin cancer	0.000149	0.000746	CcSEcCtD
Irinotecan—ABCB1—female reproductive system—skin cancer	0.000148	0.00466	CbGeAlD
Irinotecan—Confusional state—Docetaxel—skin cancer	0.000147	0.000737	CcSEcCtD
Irinotecan—Oedema—Docetaxel—skin cancer	0.000146	0.000731	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—skin cancer	0.000146	0.000731	CcSEcCtD
Irinotecan—Dizziness—Temozolomide—skin cancer	0.000145	0.000727	CcSEcCtD
Irinotecan—Infection—Docetaxel—skin cancer	0.000145	0.000726	CcSEcCtD
Irinotecan—Nausea—Dactinomycin—skin cancer	0.000144	0.000722	CcSEcCtD
Irinotecan—Shock—Docetaxel—skin cancer	0.000144	0.000719	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—skin cancer	0.000143	0.000717	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—skin cancer	0.000143	0.000715	CcSEcCtD
Irinotecan—CES1—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000142	0.0266	CbGpPWpGaD
Irinotecan—Vomiting—Temozolomide—skin cancer	0.00014	0.000699	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—skin cancer	0.000139	0.000697	CcSEcCtD
Irinotecan—Rash—Temozolomide—skin cancer	0.000139	0.000693	CcSEcCtD
Irinotecan—Diarrhoea—Fluorouracil—skin cancer	0.000139	0.000693	CcSEcCtD
Irinotecan—Dermatitis—Temozolomide—skin cancer	0.000138	0.000692	CcSEcCtD
Irinotecan—Headache—Temozolomide—skin cancer	0.000138	0.000688	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—skin cancer	0.000137	0.000683	CcSEcCtD
Irinotecan—Dizziness—Fluorouracil—skin cancer	0.000134	0.000669	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—skin cancer	0.000132	0.000661	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—skin cancer	0.000131	0.000656	CcSEcCtD
Irinotecan—Nausea—Temozolomide—skin cancer	0.000131	0.000653	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—skin cancer	0.00013	0.000651	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—skin cancer	0.00013	0.00065	CcSEcCtD
Irinotecan—Vomiting—Fluorouracil—skin cancer	0.000129	0.000644	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—skin cancer	0.000129	0.000643	CcSEcCtD
Irinotecan—ACHE—Peptide hormone metabolism—EXOC2—skin cancer	0.000129	0.0241	CbGpPWpGaD
Irinotecan—Rash—Fluorouracil—skin cancer	0.000128	0.000638	CcSEcCtD
Irinotecan—Dermatitis—Fluorouracil—skin cancer	0.000128	0.000638	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—skin cancer	0.000127	0.000635	CcSEcCtD
Irinotecan—Headache—Fluorouracil—skin cancer	0.000127	0.000634	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—skin cancer	0.000126	0.000631	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—skin cancer	0.000126	0.00063	CcSEcCtD
Irinotecan—Constipation—Docetaxel—skin cancer	0.000125	0.000625	CcSEcCtD
Irinotecan—Pain—Docetaxel—skin cancer	0.000125	0.000625	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000125	0.0234	CbGpPWpGaD
Irinotecan—ABCB1—head—skin cancer	0.000124	0.00389	CbGeAlD
Irinotecan—Feeling abnormal—Docetaxel—skin cancer	0.00012	0.000602	CcSEcCtD
Irinotecan—Nausea—Fluorouracil—skin cancer	0.00012	0.000601	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—skin cancer	0.00012	0.000598	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000118	0.0222	CbGpPWpGaD
Irinotecan—Abdominal pain—Docetaxel—skin cancer	0.000116	0.000578	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—skin cancer	0.000116	0.000578	CcSEcCtD
Irinotecan—BCHE—Peptide hormone metabolism—EXOC2—skin cancer	0.000115	0.0215	CbGpPWpGaD
Irinotecan—Hypersensitivity—Docetaxel—skin cancer	0.000108	0.000538	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—skin cancer	0.000105	0.000524	CcSEcCtD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000101	0.019	CbGpPWpGaD
Irinotecan—Diarrhoea—Docetaxel—skin cancer	0.0001	0.0005	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—skin cancer	9.67e-05	0.000483	CcSEcCtD
Irinotecan—Vomiting—Docetaxel—skin cancer	9.3e-05	0.000465	CcSEcCtD
Irinotecan—Rash—Docetaxel—skin cancer	9.22e-05	0.000461	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—skin cancer	9.21e-05	0.00046	CcSEcCtD
Irinotecan—Headache—Docetaxel—skin cancer	9.16e-05	0.000458	CcSEcCtD
Irinotecan—Nausea—Docetaxel—skin cancer	8.68e-05	0.000434	CcSEcCtD
Irinotecan—ABCB1—lymph node—skin cancer	8.65e-05	0.00272	CbGeAlD
Irinotecan—CES2—Fluoropyrimidine Activity—TP53—skin cancer	8.59e-05	0.0161	CbGpPWpGaD
Irinotecan—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—skin cancer	8.2e-05	0.0154	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—CDKN2A—skin cancer	8.18e-05	0.0153	CbGpPWpGaD
Irinotecan—UGT1A9—PPARA activates gene expression—PLIN2—skin cancer	7.94e-05	0.0149	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	7.77e-05	0.0146	CbGpPWpGaD
Irinotecan—UGT1A9—PPAR Alpha Pathway—CDK4—skin cancer	6.72e-05	0.0126	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	6.08e-05	0.0114	CbGpPWpGaD
Irinotecan—ABCC1—S1P1 pathway—PTGS2—skin cancer	5.95e-05	0.0112	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—CDK4—skin cancer	5.84e-05	0.0109	CbGpPWpGaD
Irinotecan—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	5.62e-05	0.0105	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	5.48e-05	0.0103	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	5.35e-05	0.01	CbGpPWpGaD
Irinotecan—SLC22A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.06e-05	0.00948	CbGpPWpGaD
Irinotecan—CES1—Fluoropyrimidine Activity—TP53—skin cancer	5.06e-05	0.00948	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CDKN2A—skin cancer	4.82e-05	0.00903	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.34e-05	0.00814	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—CDK4—skin cancer	3.68e-05	0.00689	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	3.47e-05	0.00649	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	3.02e-05	0.00566	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.95e-05	0.00552	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.91e-05	0.00545	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.79e-05	0.00524	CbGpPWpGaD
Irinotecan—ABCC1—Arachidonic acid metabolism—PTGS2—skin cancer	2.74e-05	0.00514	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.59e-05	0.00484	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.57e-05	0.00482	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—TP53—skin cancer	2.48e-05	0.00465	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—EXOC2—skin cancer	2.43e-05	0.00455	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—IL6—skin cancer	2.27e-05	0.00426	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.25e-05	0.00421	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—EXOC2—skin cancer	2.17e-05	0.00406	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.13e-05	0.00399	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.06e-05	0.00385	CbGpPWpGaD
Irinotecan—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	2e-05	0.00376	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2e-05	0.00375	CbGpPWpGaD
Irinotecan—ALB—SLC-mediated transmembrane transport—SLC12A2—skin cancer	1.98e-05	0.00371	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.95e-05	0.00366	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.87e-05	0.00351	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.85e-05	0.00347	CbGpPWpGaD
Irinotecan—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	1.76e-05	0.0033	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.76e-05	0.0033	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	1.63e-05	0.00306	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.63e-05	0.00305	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.44e-05	0.00269	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—IL6—skin cancer	1.43e-05	0.00268	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	1.28e-05	0.0024	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PLIN2—skin cancer	1.27e-05	0.00238	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—BRAF—skin cancer	1.23e-05	0.0023	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.22e-05	0.00228	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.12e-05	0.00209	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—BRAF—skin cancer	1.09e-05	0.00205	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.03e-05	0.00192	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CSPG4—skin cancer	1.02e-05	0.00192	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.01e-05	0.00188	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PLIN2—skin cancer	1e-05	0.00187	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PLIN2—skin cancer	9.49e-06	0.00178	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PLIN2—skin cancer	9.49e-06	0.00178	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	9.48e-06	0.00178	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—BRAF—skin cancer	9.39e-06	0.00176	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PLIN2—skin cancer	9.15e-06	0.00172	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PLIN2—skin cancer	8.93e-06	0.00167	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	8.82e-06	0.00165	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CSPG4—skin cancer	8.81e-06	0.00165	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PLIN2—skin cancer	8.7e-06	0.00163	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—BRAF—skin cancer	8.37e-06	0.00157	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CSPG4—skin cancer	8.07e-06	0.00151	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PLIN2—skin cancer	8.06e-06	0.00151	CbGpPWpGaD
Irinotecan—ALB—Vitamin B12 Metabolism—IL6—skin cancer	7.99e-06	0.0015	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PLIN2—skin cancer	7.98e-06	0.0015	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CSPG4—skin cancer	7.65e-06	0.00143	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CSPG4—skin cancer	7.65e-06	0.00143	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CSPG4—skin cancer	7.38e-06	0.00138	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CSPG4—skin cancer	7.2e-06	0.00135	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—skin cancer	7.1e-06	0.00133	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CSPG4—skin cancer	7.01e-06	0.00131	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ENO2—skin cancer	6.96e-06	0.0013	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	6.88e-06	0.00129	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL6—skin cancer	6.5e-06	0.00122	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CSPG4—skin cancer	6.49e-06	0.00122	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CSPG4—skin cancer	6.44e-06	0.00121	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	6.25e-06	0.00117	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.11e-06	0.00114	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SHH—skin cancer	5.99e-06	0.00112	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ENO2—skin cancer	5.99e-06	0.00112	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PLIN2—skin cancer	5.91e-06	0.00111	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PLIN2—skin cancer	5.77e-06	0.00108	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—skin cancer	5.63e-06	0.00106	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ENO2—skin cancer	5.48e-06	0.00103	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ENO2—skin cancer	5.2e-06	0.000975	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ENO2—skin cancer	5.2e-06	0.000975	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IL6—skin cancer	5.17e-06	0.000968	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—skin cancer	5.03e-06	0.000941	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ENO2—skin cancer	5.02e-06	0.00094	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PLIN2—skin cancer	4.97e-06	0.000931	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ENO2—skin cancer	4.89e-06	0.000916	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FOXO4—skin cancer	4.88e-06	0.000915	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ENO2—skin cancer	4.77e-06	0.000893	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CSPG4—skin cancer	4.76e-06	0.000892	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CSPG4—skin cancer	4.65e-06	0.000872	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.47e-06	0.000837	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ENO2—skin cancer	4.41e-06	0.000827	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ENO2—skin cancer	4.38e-06	0.00082	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PLIN2—skin cancer	4.36e-06	0.000816	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—skin cancer	4.32e-06	0.000809	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.29e-06	0.000803	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.07e-06	0.000762	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ERCC2—skin cancer	4.05e-06	0.000758	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CSPG4—skin cancer	4.01e-06	0.000751	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.92e-06	0.000735	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—skin cancer	3.85e-06	0.000721	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.83e-06	0.000717	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.73e-06	0.000698	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CSPG4—skin cancer	3.51e-06	0.000658	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERCC2—skin cancer	3.48e-06	0.000652	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TERT—skin cancer	3.26e-06	0.000611	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ENO2—skin cancer	3.24e-06	0.000606	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ERCC2—skin cancer	3.18e-06	0.000597	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ENO2—skin cancer	3.16e-06	0.000592	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ERCC2—skin cancer	3.02e-06	0.000566	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ERCC2—skin cancer	3.02e-06	0.000566	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.99e-06	0.000561	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ERCC2—skin cancer	2.91e-06	0.000546	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ERCC2—skin cancer	2.84e-06	0.000532	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ERCC2—skin cancer	2.77e-06	0.000519	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ENO2—skin cancer	2.72e-06	0.00051	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PLIN2—skin cancer	2.68e-06	0.000503	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.66e-06	0.000498	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BRAF—skin cancer	2.58e-06	0.000484	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ERCC2—skin cancer	2.56e-06	0.00048	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ERCC2—skin cancer	2.54e-06	0.000476	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—skin cancer	2.43e-06	0.000454	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ENO2—skin cancer	2.39e-06	0.000447	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CSPG4—skin cancer	2.16e-06	0.000405	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.13e-06	0.000399	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—skin cancer	2.09e-06	0.000391	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—skin cancer	1.91e-06	0.000358	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ERCC2—skin cancer	1.88e-06	0.000352	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ERCC2—skin cancer	1.84e-06	0.000344	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—skin cancer	1.82e-06	0.000341	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—skin cancer	1.81e-06	0.000339	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—skin cancer	1.81e-06	0.000339	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—skin cancer	1.75e-06	0.000327	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—skin cancer	1.7e-06	0.000319	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—skin cancer	1.66e-06	0.000311	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—skin cancer	1.62e-06	0.000304	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ERCC2—skin cancer	1.58e-06	0.000296	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—skin cancer	1.57e-06	0.000294	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—skin cancer	1.54e-06	0.000288	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—skin cancer	1.52e-06	0.000285	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO2—skin cancer	1.47e-06	0.000275	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—skin cancer	1.4e-06	0.000262	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—skin cancer	1.39e-06	0.000261	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ERCC2—skin cancer	1.39e-06	0.00026	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—skin cancer	1.33e-06	0.000249	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—skin cancer	1.19e-06	0.000222	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—skin cancer	1.14e-06	0.000213	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—skin cancer	1.13e-06	0.000211	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—skin cancer	1.1e-06	0.000206	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—skin cancer	9.49e-07	0.000178	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ERCC2—skin cancer	8.54e-07	0.00016	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—skin cancer	8.31e-07	0.000156	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—skin cancer	5.12e-07	9.59e-05	CbGpPWpGaD
